Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

PSMA-PET leverages ‘radiotracers’ that bind to prostate cancer cells, making them visible on PET scans and providing functional imaging that reveals the biological activity of cancer.

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

Joseph Renzulli, MD, Associate Professor of Urology at Yale School of Medicine, discusses how the scope of the utilization of PET scans has expanded based on the success of PSMA. (1:33 ...

PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

Malaysia, meanwhile, is emerging as a prominent leader in adopting advanced prostate cancer treatments and diagnostics, including Prostate-Specific Membrane Antigen (PSMA) PET scans and ...

APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and a presentation by Dr.

1 To better understand the potential impact of more-sensitive imaging techniques, investigators at the University of California, Los Angeles (UCLA), analyzed PSMA-PET/CT scans from 182 patients ...

“Now, there are probably about 300,000 PSMA/PET scans per year in the U.S., and the studies at UCLA-UCSF really set the stage for that.” That clinical research paved the way for UCLA to become ...

PSMA-PET imaging represents a significant advancement in prostate cancer management, providing clinicians with more information than conventional imaging methods (bone scan, CT [4] scan ...